Through CRISPR Cas9, the anti-tumor effect can be greatly improved through knockout of cancer-causing genes, such as DNA methyltransferase 1 (DNMT1) gene [175], survivine gene [176], and EGFR gene [177]. Here, DNMT1 is linked to neoplasm.